Skip to content
MatchScript
Menu

Evidence review

How Much Does Tirzepatide Cost Without Insurance? (2026 Telehealth Pricing)

Brand Zepbound self-pay price vs. compounded tirzepatide telehealth pricing, what's included, and HSA/FSA — real 2026 tirzepatide costs without insurance.

By The MatchScript Team, Matching & Recommendations Desk

If you're paying for tirzepatide out of pocket, what you actually pay depends almost entirely on whether you buy FDA-approved brand-name Zepbound or a compounded version through a telehealth provider — and, as with semaglutide, the gap is large. This is a straight, sourced breakdown of what tirzepatide costs without insurance in 2026: the brand self-pay price, what telehealth providers charge for compounded tirzepatide, what drives the range, and what's really included. Every provider price below reflects the published pricing of the telehealth companies we track (last reviewed 2026) — no invented numbers.

The short answer

Without insurance, brand-name tirzepatide (Zepbound) single-dose vials now run about $299 to $449 a month through the manufacturer's self-pay pharmacy depending on dose23, down sharply from a retail list price around $1,086 a month. Compounded tirzepatide through a telehealth provider commonly runs about $145 to $349 a month, with a few disclosed prices lower and premium tiers at the top of that band. So the honest range for a cash payer is roughly $110 to $449 a month depending on which path you choose — and the rest of this guide explains what actually moves you within that range. Note that tirzepatide typically costs more than semaglutide at the same provider.

Brand-name Zepbound: list price vs. the new self-pay price

Zepbound is FDA-approved tirzepatide, indicated as an adjunct to diet and exercise for chronic weight management1. Its retail list price has sat around $1,086 a month, the number that kept cash payers away.

That's changed. Through Eli Lilly's direct self-pay channel, single-dose Zepbound vials are sold to cash patients at reduced monthly prices tiered by dose — roughly $299 a month for the 2.5 mg starter, about $399 for 5 mg, and about $449 for the higher doses, when refilled on schedule23. These vials are a cash-only product — no insurance and no pharmacy discount cards apply — but they get you the FDA-approved medication for roughly a quarter of the retail pen price3. In other words, buying the brand for cash is far cheaper than it used to be.

Compounded tirzepatide: what telehealth actually charges

Compounded tirzepatide is prepared by a licensed pharmacy rather than sold as an FDA-approved finished product — the FDA does not review its safety, effectiveness, or quality before it reaches patients4. That's the trade-off behind its lower price. Across the telehealth providers we track, compounded tirzepatide most commonly lands in the $145–$349 a month band. At the low end, a few providers disclose prices around $110–$166; in the middle sit a cluster of plans around $199–$299; and premium or brand-adjacent tiers reach $349–$399.

For a concrete anchor: our top-ranked pick prices compounded tirzepatide at $349 a month flat, the same molecule that costs far more as brand, with no intro-rate step-up. You can line up every provider's real tirzepatide price with our cost calculator, which pulls the same disclosed numbers and lets you total them over 3, 6, or 12 months. Or browse the full cash-pay GLP-1 board for nationwide, no-lock-in and brand-name picks.

What drives the price range

Four things move a compounded price:

The medication and dose. Tirzepatide is generally priced above semaglutide, and higher maintenance doses can cost more at some pharmacies — though many telehealth plans charge one flat monthly price regardless of dose.

Whether it's a teaser or a maintenance price. Some providers advertise a low first-month rate that steps up sharply afterward. Because a GLP-1 is usually a multi-year commitment, the maintenance price — not the intro rate — is the number that matters.

What's bundled in. A plan that includes clinician visits, dose adjustments, labs, and shipping can be cheaper in total than a lower sticker that bills those separately.

Brand vs. compounded, and legal basis. Broad shortage-based compounding of tirzepatide is winding down now that the FDA has declared the shortage resolved and set deadlines for compounders5. That's reshaping the market, so a provider's transparency about the legal basis for what it dispenses is part of the value — see our deeper look at compounded vs. brand-name GLP-1s.

What's included — consult, labs, and shipping

The sticker price is only meaningful once you know what it covers. On most reputable telehealth tirzepatide programs, the monthly fee bundles the medication, the asynchronous or live clinician consultation and prescription, ongoing dose adjustments, and shipping. Some also include or require baseline lab work; others treat labs as a separate cost. A "cheap" plan that adds a consult fee, a shipping fee, and lab charges on top can quietly cost more than an all-in plan that looked pricier up front. When you compare, compare the total — which is exactly what the comparison hub is built to do.

Plan-length discounts and the maintenance-price trap

Almost every telehealth provider discounts longer commitments: paying quarterly or for a full course usually beats month-to-month. That can be a real saving if you're confident tirzepatide is right for you — but prepaying also locks you in, so it cuts both ways. The bigger trap is the teaser rate. A plan advertised at a low first month that becomes far more for months two onward is really priced at the ongoing number. Always find the ongoing price and multiply it out; our guide to picking a provider for long-term use explains why the maintenance number is the one that matters.

HSA/FSA and other ways to lower the cost

Tirzepatide prescribed for a diagnosed medical condition is generally an eligible expense for an HSA or FSA, letting you pay with pre-tax dollars and effectively shave your marginal tax rate off the price — worth confirming with your plan administrator. Beyond that: choose an all-in flat plan to avoid surprise add-ons, use manufacturer self-pay pricing if you want the brand, use plan-length discounts only once you're committed, and compare the maintenance price rather than the intro rate. If you're also weighing semaglutide — which is usually cheaper — our semaglutide vs. tirzepatide guide covers the price and efficacy trade-off, and semaglutide cost without insurance breaks down that molecule.

So what should you actually budget?

Tirzepatide is the higher-efficacy molecule — SURMOUNT-1 showed average weight loss up to roughly 21% at the top dose6 — and it typically costs more than semaglutide to match. For most cash payers, a realistic 2026 budget is about $200 to $350 a month for a solid, all-in compounded tirzepatide program, or roughly $299 to $449 a month for FDA-approved Zepbound vials through the manufacturer's self-pay pharmacy23. Below roughly $150 you can find legitimate compounded options in some states, but scrutinize what's bundled and whether the price is a teaser.

Not sure which plan fits your budget and molecule? The 2-minute quiz weighs budget, molecule, and support into our honest Match Score and surfaces providers that fit, our best tirzepatide providers board ranks the field, or you can run the numbers yourself in the cost calculator. You can also weigh our top-ranked flat-price match below.

Frequently asked questions

How much is tirzepatide per month without insurance?

In 2026, FDA-approved Zepbound single-dose vials run about $299–$449 a month through Eli Lilly's self-pay pharmacy depending on dose, down from a retail list price near $1,086. Compounded tirzepatide through a telehealth provider commonly runs about $145–$349 a month, with a few disclosed prices lower and premium tiers up to roughly $399.

Why is compounded tirzepatide cheaper than Zepbound?

Compounded tirzepatide isn't an FDA-approved finished product, so the FDA doesn't review its safety, effectiveness, or quality before it reaches patients — which is much of the reason it costs less. The trade-off is that you rely on the pharmacy's quality and the provider's oversight instead of an FDA approval of that exact product.

Is tirzepatide more expensive than semaglutide?

Usually, yes. At most telehealth providers, compounded tirzepatide is priced above compounded semaglutide, and the brand self-pay prices follow the same pattern. Tirzepatide is also the higher-efficacy molecule, so many people accept the higher price for the stronger average weight loss.

Can I use an HSA or FSA to pay for tirzepatide?

Generally yes — tirzepatide prescribed for a diagnosed condition is usually an eligible HSA/FSA expense, letting you pay with pre-tax dollars. Confirm the specifics with your plan administrator, since rules vary by plan.

References

  1. U.S. Food and Drug Administration (2023). Zepbound (tirzepatide) injection — Prescribing Information (label). FDA / Drugs@FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf
  2. Eli Lilly and Company (2026). Zepbound (tirzepatide) — Coverage & Savings (self-pay pricing). Zepbound.lilly.com. https://www.zepbound.lilly.com/coverage-savings
  3. Pharmaceutical Executive (2025). Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients. Pharmaceutical Executive (PharmExec.com). https://www.pharmexec.com/view/lilly-reduces-price-of-zepbound-single-dose-vials-for-self-pay-patients
  4. U.S. Food and Drug Administration (2024). Compounding and the FDA: Questions and Answers. FDA. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  5. U.S. Food and Drug Administration (2025). FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. FDA Drug Alerts and Statements. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
  6. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Continue reading